Neurocrine Biosciences initiates clinical-stage development of IL-4 fusion toxin May 19, 1998 No Comments
DAB389IL-7, a novel fusion protein for the specific elimination of IL-7 receptor-positive cells May 12, 1998 No Comments
Efficacy of StressGen's HspE7 in preclinical cancer models reported at FASEB 98 April 28, 1998 No Comments
RSS